modelVericiguat_Ruehs2021_reference
Extends from Pharmacolibrary.Pharmacokinetic.Models.PK_1C_enteral.
Information
| name: | vericiguat |
| ATC code: | C01DX22 |
| model: | one compartment, oral dosing (PK_1C_enteral) |
| source: | Ruehs H et al. 2021 |
| population: | adults with heart failure and reduced ejection fraction |
| measured compound: | vericiguat |
| review: | accepted with caveats |
| record page: | pharmacolibrary-docs |
Parameters as reported in the paper
| parameter | value | unit | meaning |
|---|---|---|---|
| CL/F (L/h) | 1.3 | L/h | CL/F |
| V/F (L) | 38.9 | L | V/F |
| ka (1/h) | 1.5 | 1/h | kabs |
| v_sex | 0.850 | equation variable | |
| theta_q22_creatinine_power | 0.164 | equation variable | |
| theta_kabs_bodyweight_ka | 1.28 | equation variable | |
| theta_kabs_albumin_power | 2.37 | equation variable |
About vericiguat
Vericiguat is a vasodilator used to treat heart failure. It is approved and authorised in the European Union, though it also remains investigational for other uses.
Summary written by glm-5.3-flash from Wikidata Q27283201 and the WHO ATC classification and the EMA medicines list; not checked by a person.
Identity, molar mass and metabolites: Vericiguat.
References
Ruehs H et al. (2021). Population Pharmacokinetics and Pharmacodynamics of Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction. Clinical pharmacokinetics 60(11):1407–1421. DOI:10.1007/s40262-021-01024-y PUBMED:34086190
Parameters
| Type | Name | Default | Description |
|---|---|---|---|
| Real | Cl_ref | 3.611111111111112e-07 | Cl [m3/s] |
| Real | cov_sex_0 | 0 | sex covariate |
| Real | Vd_ref | 0.0389 | Vd [m3] |
| Modelica.Units.SI.Mass | weight (from PK_1C) | 75 | patient weight (kg) |
| Modelica.Units.SI.SpecificVolume | VdPerKg (from PK_1C) | 0.0009 | Volume of distribution per kg (default 0.9 L/kg) |
| Modelica.Units.SI.MassFraction | F (from PK_1C) | 1 | bioavailability (0-1) |
| Pharmacolibrary.Types.Clearance | Cl (from PK_1C) | 2.7777777777777776e-7 | clearance |
| Modelica.Units.SI.Time | adminTime (from PK_1C) | 60 | first administration time (s) |
| Modelica.Units.SI.Time | adminDuration (from PK_1C) | 600 | administration duration (s) |
| Modelica.Units.SI.Time | adminPeriod (from PK_1C) | 8*60*60 | period of administration (default 8 hours)(s) |
| Pharmacolibrary.Types.Mass | adminMass (from PK_1C) | 1e-4 | administration mass (mg) |
| Integer | adminCount (from PK_1C) | 8 | number of dose administered (1) |
| Pharmacolibrary.Types.Volume | Vd (from PK_1C) | VdPerKg*weight | Volume of distribution (m3) |
| Pharmacolibrary.Types.TransferRate | ka (from PK_1C_enteral) | 0.016666666666666666 | first order absorption rate |
| Modelica.Units.SI.Time | Tlag (from PK_1C_enteral) | 600 | delay between oral administration and absorption (default 10min) |
| Info › Therapeutic range (metadata, not used in equations) | |||
| Pharmacolibrary.Types.MassConcentration | Cmin (from PK_1C) | 0.004 | minimal therapeutic range |
| Pharmacolibrary.Types.MassConcentration | Cmax (from PK_1C) | 0.008 | maximal therapeutic range |
| Pharmacolibrary.Types.MassConcentration | Ctox_peak (from PK_1C) | 0.012 | toxicity peak level |
| Pharmacolibrary.Types.MassConcentration | Ctox_trough (from PK_1C) | 0.006 | toxicity trough level |
| Info › Substance metadata | |||
| Modelica.Units.SI.MolarMass | MM (from PK_1C) | 0 | molar mass [kg/mol]; 0 = not supplied (molar concentrations are then 0) |
| Info › Substance metadata (not used in equations) | |||
| Pharmacolibrary.Types.Dose | LD50 (from PK_1C) | 0 | median lethal dose [mg/kg]; 0 = unknown |
Connectors
| Type | Name | Default | Description |
|---|---|---|---|
| Types.ConcentrationOutput | C_central (from PK_1C) | ||
| Interfaces.ConcentrationPort_b | centralCPort (from PK_1C) |
Components
| Type | Name | Default | Description |
|---|---|---|---|
| Pharmacokinetic.NoPerfusedTissueCompartment | central (from PK_1C) | ||
| Pharmacokinetic.ClearanceDrivenElimination | elim (from PK_1C) | ||
| Sources.PeriodicDose | periodicDose (from PK_1C) | ||
| Modelica.Units.SI.Time | t1_2 (from PK_1C) | central-compartment elimination half-life = ln(2)*Vd/Cl (1-compartment approximation; NOT the terminal half-life of 2-/3-compartment models) |
Revisions
- 11/2026 generated by pharmacolibrary-dev export.pharmacolibrary_models from Ruehs_2021: parameters extracted from the paper by the pharmacolibrary-dev pipeline, model built by its engineer, reviewed: accepted with caveats